Browse by Palliative Care

Pharmaceutical Benefits for Palliative Care

PREPARATIONS WHICH MAY BE PRESCRIBED FOR PATIENTS RECEIVING PALLIATIVE CARE

The prescribing of medications listed in this section is in accordance with the requirements for General Pharmaceutical Benefits in the Schedule unless otherwise detailed in the listing for the item.

In addition, certain additional principles have been applied by the Pharmaceutical Benefits Advisory Committee (PBAC) in recommending the patients for whom these medications may be prescribed, and the number of repeats that may be approved by Department of Human Services. These principles have been encompassed in the listings for the items, and further details are provided below to assist doctors prescribing under this section.

For the purposes of this section a patient receiving palliative care is defined as:

  • A patient with an active, progressive, far-advanced disease for whom the prognosis is limited and the focus of care is the quality of life.

Most palliative care listings are available as “Authority Required” (Streamlined) or Restricted Benefits, intended to provide up to four months therapy in total (as an original prescription with repeats). Subsequent continuing therapy can be prescribed on consecutive occasions under these listings if required.

Prior approval from the Department of Human Services is not required to prescribe an ‘Authority Required’ (Streamlined) item where the quantity and number of repeats are not more than stated in the listing. “Authority Required” (Streamlined) items are written on an authority prescription form and must include a four-digit streamlined authority code.

Prior approval from the Department of Human Services or the Department of Veterans’ Affairs (DVA) is required for each prescription to prescribe quantities and/or repeats above the number in the listing. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying Medicines — What Pharmacists Need to Know, for more information on authority prescriptions.) For prior DVA approval to prescribe certain palliative care medicines not included in the PBS Palliative Care Section please contact Veterans' Affairs Pharmaceutical Approvals Centre.

State and Territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their State/Territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the responsibility of all prescribers to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.

When a Palliative Care authority application is for an opioid, the following guidelines apply:

  • the maximum quantity authorised is generally for 1 month’s therapy;
  • where supply for a longer period is warranted, quantities for up to 3 months’ therapy may be approved via written applications.

Prescribers should state (on the prescription) the interval of repeat where repeats are called for, and ensure State/Territory health authorities are notified about ongoing treatment.

Prescribers may also prescribe PBS items included in the general Schedule for patients receiving palliative care. This includes opioid preparations, according to the restrictions that apply to individual items and the requirements that apply to the general Schedule.

Further information can be found in the factsheets.

  • Legend
  • PPalliative care items
  • MPMedical Practitioner
  • NPNurse Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MPNP 10600X FENTANYLfentanyl 200 microgram sublingual tablet, 10 2 20 0
MPNP 10612M FENTANYLfentanyl 800 microgram sublingual tablet, 10 1 10 0
MPNP 5405L FENTANYLFENTANYL Lozenge 1200 micrograms (as citrate), 9 1 9 0
MPNP 10723J FENTANYLfentanyl 800 microgram orally disintegrating tablet, 4 2 8 0
MPNP 5411T FENTANYLFENTANYL Lozenge 1200 micrograms (as citrate), 30 2 60 0
MPNP 5404K FENTANYLFENTANYL Lozenge 800 micrograms (as citrate), 9 1 9 0
MPNP 5406M FENTANYLFENTANYL Lozenge 1600 micrograms (as citrate), 9 1 9 0
MPNP 5402H FENTANYLFENTANYL Lozenge 400 micrograms (as citrate), 9 1 9 0
MPNP 10739F FENTANYLfentanyl 400 microgram orally disintegrating tablet, 4 2 8 0
MPNP 5410R FENTANYLFENTANYL Lozenge 800 micrograms (as citrate), 30 2 60 0
MPNP 10607G FENTANYLfentanyl 200 microgram sublingual tablet, 30 2 60 0
MPNP 10610K FENTANYLfentanyl 300 microgram sublingual tablet, 30 2 60 0
MPNP 10604D FENTANYLfentanyl 600 microgram sublingual tablet, 10 1 10 0
MPNP 5403J FENTANYLFENTANYL Lozenge 600 micrograms (as citrate), 9 1 9 0
MPNP 5408P FENTANYLFENTANYL Lozenge 400 micrograms (as citrate), 30 2 60 0
MPNP 10738E FENTANYLfentanyl 800 microgram orally disintegrating tablet, 28 2 56 0
MPNP 10602B FENTANYLfentanyl 100 microgram sublingual tablet, 30 2 60 0
MPNP 10722H FENTANYLfentanyl 600 microgram orally disintegrating tablet, 4 2 8 0
MPNP 5401G FENTANYLFENTANYL Lozenge 200 micrograms (as citrate), 9 1 9 0
MPNP 10713W FENTANYLfentanyl 600 microgram orally disintegrating tablet, 28 2 56 0
MPNP 10613N FENTANYLfentanyl 600 microgram sublingual tablet, 30 2 60 0
MPNP 10601Y FENTANYLfentanyl 100 microgram sublingual tablet, 10 2 20 0
MPNP 10698C FENTANYLfentanyl 200 microgram orally disintegrating tablet, 28 2 56 0
MPNP 10684H FENTANYLfentanyl 100 microgram orally disintegrating tablet, 28 2 56 0
MPNP 10603C FENTANYLfentanyl 400 microgram sublingual tablet, 10 1 10 0
MPNP 10729Q FENTANYLfentanyl 100 microgram orally disintegrating tablet, 4 2 8 0
MPNP 5407N FENTANYLFENTANYL Lozenge 200 micrograms (as citrate), 30 2 60 0
MPNP 10608H FENTANYLfentanyl 400 microgram sublingual tablet, 30 2 60 0
MPNP 10606F FENTANYLfentanyl 300 microgram sublingual tablet, 10 1 10 0
MPNP 5409Q FENTANYLFENTANYL Lozenge 600 micrograms (as citrate), 30 2 60 0
MPNP 10697B FENTANYLfentanyl 200 microgram orally disintegrating tablet, 4 2 8 0
MPNP 10737D FENTANYLfentanyl 400 microgram orally disintegrating tablet, 28 2 56 0
MPNP 10611L FENTANYLfentanyl 800 microgram sublingual tablet, 30 2 60 0
MPNP 5412W FENTANYLFENTANYL Lozenge 1600 micrograms (as citrate), 30 2 60 0